UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Date of Report (Date of earliest event reported):  May 6, 2014

 

BOSTON SCIENTIFIC CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Registrant’s telephone number, including area code:  (508) 650-8000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o  Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

ITEM 5.07.                               SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

 

(a)                                 Boston Scientific Corporation (the “Company”) held its 2014 Annual Meeting of Stockholders (the “Annual Meeting”) on May 6, 2014 at its Corporate Headquarters located in Natick, Massachusetts.

 

(b)                                 The final voting results on each of the matters submitted to a vote of stockholders at the Annual Meeting are set forth below.

 

(1)                     All eleven director nominees were elected to the Company’s Board of Directors for a one-year term to hold office until the Company’s 2015 Annual Meeting of Stockholders and until their successors have been elected and qualified.

 

Nominee		For		Withheld		Broker Non-Votes
Bruce L. Byrnes		1,060,505,874		7,245,394		72,859,222
Nelda J. Connors		1,059,563,807		8,187,461		72,859,222
Kristina M. Johnson		1,062,539,427		5,211,841		72,859,222
Edward J. Ludwig		1,063,292,389		4,458,879		72,859,222
Michael F. Mahoney		1,056,550,951		11,200,317		72,859,222
Ernest Mario		955,297,133		112,454,135		72,859,222
N.J. Nicholas, Jr.		1,051,151,453		16,599,815		72,859,222
Pete M. Nicholas		1,050,003,145		17,748,123		72,859,222
Uwe E. Reinhardt		1,053,874,765		13,876,503		72,859,222
David J. Roux		1,063,362,956		4,388,312		72,859,222
John E. Sununu		1,059,092,516		8,658,752		72,859,222

 

(2)                     The advisory vote on the compensation for the Company’s “Named Executive Officers” as disclosed in the Company’s proxy statement for the Annual Meeting (the “Proxy Statement”) was approved.

 

For		Against		Abstain		Broker Non-Votes
953,886,735		107,834,346		6,030,187		72,859,222

 

(3)                     The amendment and restatement of the Company’s 2006 Global Employee Stock Ownership Plan, as amended, was approved.

 

For		Against		Abstain		Broker Non-Votes
1,052,420,894		8,758,738		6,571,636		72,859,222

 

(4)                     The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2014 fiscal year was ratified.

 

For		Against		Abstain		Broker Non-Votes
1,128,909,538		9,567,795		2,133,157		N/A

 

(5)                     The stockholder proposal regarding accountability in animal experimentation as described in the

 

2

 

Proxy Statement was not approved.

 

For		Against		Abstain		Broker Non-Votes
40,915,396		786,785,293		240,050,579		72,859,222

 

3

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	BOSTON SCIENTIFIC CORPORATION
Date:  May 8, 2014	By:	/s/ Vance R. Brown
	Vance R. Brown
	Vice President and Chief Corporate Counsel

 

4